Among the many myths advanced to help inflate perceptions of Obamacare’s success is the lore that the new exchanges are sites of robust competition and choice.
Since China is an adversary, reliance on the country for critical drugs carries national security implications. Additionally, in all of 2014, FDA inspectors only performed 117 inspections of Chinese drug manufacturing facilities.
The woeful inadequacy of organ-procurement policy lies in its ideological bedrock: the notion that altruism–that is, sacrifice without expectation of material reciprocation or enrichment–is the only legitimate motive for donating an organ.
Yesterday, Jonathan Gruber’s hearing before the House Oversight and Government Reform Committee left several key questions unanswered.
The ACA’s “delivery system reforms” have nothing to do with current trends.
Jonathan Gruber apologized before Congress for his “stupidity” comments, but his comments were made as laugh lines at academic conferences, which shows his disrespect for the judgement of Americans.
Rather than have the government ration care, or patients, under Medicare, a new bipartisan “reform” bill’s idea is to have the providers do that reconciliation.
Republicans need to devise a conservative health-care plan that replaces Obamacare without threatening people’s coverage.
Here’s a dirty little secret about recent attempts to fix ObamaCare. The “reforms,” approved by Senate and House leaders this summer and set to advance in the next Congress, adopt many of the Medicare payment reforms already in the Affordable Care Act.